STAT
SEPTEMBER 3, 2024
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a calculator, used by all Boston Children’s Hospital clinicians, to judge the youngest childrens’ risk. Did the infant have a high fever?
PharmaVoice
SEPTEMBER 3, 2024
As the agency considers eliminating adcomm votes from the approval process, members vie to have their voices heard.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 3, 2024
Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. Searle. She was told she had three years to live. Twenty-eight years later, Giusti, 65, is thriving. One reason is the patient advocacy group she founded in 1998: the Multiple Myeloma Research Foundation. The group has raised more than $600 million for research, launched nearly 100 clinical trials, and helped bring more than 15 new drugs to market.
BioPharma Dive
SEPTEMBER 3, 2024
While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
STAT
SEPTEMBER 3, 2024
I was in high school when I first encountered the ruthlessness of the number one killer in the U.S. A close friend of mine, then only 16 years old, witnessed his father having a heart attack while checking the mail. Despite desperate attempts at CPR on the driveway, he wasn’t able to save his dad, a seemingly healthy man in his early 40s. That event put me on a path to become a cardiologist.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 3, 2024
EU had no grounds to probe Illumina's takeover of Grail, says ECJ, but while spinoff has already taken place Illumina can now avoid a €432m fine
STAT
SEPTEMBER 3, 2024
Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI drug developer. The Salt Lake City company’s treatment is for cerebral cavernous malformation , or CCM, a potentially life-threatening condition that causes vessels in the brain to become enlarged and irregular, sometimes causing blood to leak into the brain or spinal cord.
The Pharmacist
SEPTEMBER 3, 2024
Disproportionately low pharmacy provision and over-reliance on one pharmacy group could put rural areas at risk of becoming a 'pharmacy desert', the National Pharmacy Association (NPA) has warned. And above-average levels of closures in deprived areas risk widening health inequalities, the association added. In new analysis published today, the NPA found that 87% of local […] The post NPA warns of 'pharmacy deserts' in rural and deprived areas appeared first on The Pharmacist.
STAT
SEPTEMBER 3, 2024
With new vaccine data released Tuesday, Vaxcyte, a San Carlos, Calif.-based firm, emerged as one of biotechnology’s hottest David-vs.-Goliath stories as the company seeks to challenge one of Pfizer’s biggest franchises: the Prevnar vaccine against pneumococcal disease. Shares in the company rocketed up 36% on the new data — released via press release — bringing the stock’s gain over the past 12 months to 115%.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
SEPTEMBER 3, 2024
A digital version of the NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year, according to the government.The Department of Health and Social Care (DHSC) has said the digital alternative to the current system of in-person health checks will be ready for testing in early 2025, with pilots planned for Norfolk, Medway, and Lambeth in London.
STAT
SEPTEMBER 3, 2024
Every day, physicians use clinical algorithms to make decisions about the patients in their exam rooms. To help weigh a patient’s surgical risk or likelihood of disease, they factor in attributes such as blood pressure, age, weight, surgical history — and in some cases, a patient’s race. Like many clinical researchers, bioinformatician Shyam Visweswaran started learning about those race-based tools in 2020, when a catalyzing New England Journal of Medicine paper laid out 13
The Pharmacist
SEPTEMBER 3, 2024
NHS England (NHSE) has issued advice on the role of community pharmacies in supporting individuals who will be released early from prison in the coming weeks. A letter from NHSE has flagged the potential for Pharmacy First and the Pharmacy Contraception Service to be used to support those being let out of prison as part […] The post NHSE issues advice to pharmacies ahead of early release of prisoners appeared first on The Pharmacist.
STAT
SEPTEMBER 3, 2024
Algorithms are ubiquitous in medicine. They can take the form of a flowchart, a simple equation, or a complicated AI model, and are used to help clinicians diagnose diseases, predict the chances of survival, and determine if a patient is eligible for certain treatments. Many of these algorithms take a person’s race into account. For example, if the person is Black, a clinician may add or subtract a point from the patient’s score, which can affect their treatment.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
SEPTEMBER 3, 2024
Scaling your business with a Contract Development and Manufacturing Organization (CDMO) is crucial for biopharmaceutical companies seeking to expedite the transition from preclinical development to clinical manufacturing. CDMOs play a vital role in providing expertise in process development and scale-up manufacturing, allowing biotech companies to adapt to changing market dynamics and client needs.
STAT
SEPTEMBER 3, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in multiple myeloma for decades, see mixed but promising results from Sanofi’s multiple sclerosis drug, and hear why All of Us should not be defunded.
Outsourcing Pharma
SEPTEMBER 3, 2024
Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.
STAT
SEPTEMBER 3, 2024
Greece’s antitrust regulator is investigating allegations that, over a nine-year period, Novartis paid doctors and institutions to prescribe a pricey treatment for a serious eye disease and also disparaged rival medicines. In a brief statement, the Hellenic Competition Commission disclosed it is probing evidence the company paid physicians for travel to conferences and participation in studies in order to boost sales of Lucentis, which is used to treat age-related macular degeneration, a
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
SEPTEMBER 3, 2024
Reimagine Care, the leading provider of on-demand cancer care, and Memorial Hermann Health System, one of Texas's largest not-for-profit health systems, have announced an ambitious multi-year expansion of their pioneering partnership.
STAT
SEPTEMBER 3, 2024
LONDON — Europe’s top court on Tuesday ruled that regulators overstepped in challenging the DNA sequencing behemoth Illumina’s acquisition of Grail, finding that the European Commission did not have jurisdiction over the deal. The decision won’t have a major impact on the Illumina-Grail relationship, with Illumina having divested the cancer screening company over the summer.
Outsourcing Pharma
SEPTEMBER 3, 2024
Global health technology company myTomorrows announced a new partnership on Tuesday (Aug 27) with Pancreatic Cancer Europe (PCE), a multi-stakeholder platform dedicated to improving care for pancreatic cancer patients.
STAT
SEPTEMBER 3, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Good morning! You know that part of “Little Women” (2019) when Jo says “I can’t believe that childhood is over,” while collapsed on the ground at her sister’s feet? That’s how I feel about summer ending.
pharmaphorum
SEPTEMBER 3, 2024
New data for Valneva and Pfizer's Lyme disease vaccine bolsters the case for the shot as the results of a phase 3 programme are awaited.
Pharmaceutical Technology
SEPTEMBER 3, 2024
The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.
Express Pharma
SEPTEMBER 3, 2024
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Amantadine extended-release capsules, 68.5 mg, and tentative approval for 137 mg (USRLD: Gocovri (amantadine) extended-release capsules, 68.5 mg and 137 mg). Amantadine extended-release capsules are indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.
Pharmaceutical Technology
SEPTEMBER 3, 2024
In clinical supplies, the Importer of Record (IoR) provides a critical service in facilitating logistics and easing the burden for sponsors.
pharmaphorum
SEPTEMBER 3, 2024
EU follows through on plan to revoke approval for Advanz Pharma's Ocaliva for rare disease primary biliary cholangitis (PBC)
Pharmaceutical Technology
SEPTEMBER 3, 2024
There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.
pharmaphorum
SEPTEMBER 3, 2024
Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD.Just-reported data from that study has shown that Vaxcyte's VAX-31 shot was able to stimulate a strong immune response against all 31 serotypes of Streptococcus pneumoniae included in the formulation, in adults aged 50 and over.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
How can industry stakeholders ensure the quality and supply chain security of existing product?
pharmaphorum
SEPTEMBER 3, 2024
Discover the latest hiring news and updates in the pharma and biotech industry for August 2024, featuring companies like AstraZeneca, Pfizer, BioMarin, 4DMT and more. Stay informed about the changing faces of these leading organisations.
PioneerRx
SEPTEMBER 3, 2024
Pharmacy work goes beyond putting pills in a vial. Pharmacists are invaluable parts of the healthcare industry, offering guidance, support, and care to patients.
EMCrit Project
SEPTEMBER 3, 2024
All the Resuscitation and Acute Critical Care goodness in the literature for September 2024 EMCrit Project by Scott Weingart, MD FCCM.
Expert insights. Personalized for you.
363 
Let's personalize your content